Secondary Prevention of ASCVD: Novel Therapies to Improve Outcomes in Patients with Hypercholesterolemia is organized by Medical Communications Media (MCM) Education and will be held during May 16, 2017 - May 31, 2019.
The target audience for this medical event is Cardiologists. This CME Conference has been approved for a maximum of 1.0 contact hour of continuing education.
This activity will examine the current discussions surrounding statin use and the potential application of PCSK9 inhibitors.
Additional details will be posted as soon as they are available.